Retinopathy of Prematurity

Overview


Plain-Language Overview

Retinopathy of Prematurity is a condition that affects the eyes of babies born very early or with very low birth weight. It involves abnormal growth of blood vessels in the retina, the part of the eye that senses light and sends signals to the brain. This abnormal vessel growth can cause vision problems or even blindness if severe. The condition mainly affects the retinal blood vessels and can lead to scarring or retinal detachment. Early detection is important because the disease can progress quickly during the first few weeks after birth. It is a significant cause of childhood blindness worldwide, especially in premature infants.

Clinical Definition

Retinopathy of Prematurity (ROP) is a disorder of the developing retinal vasculature in premature infants, characterized by disorganized retinal blood vessel growth and subsequent fibrosis. It occurs due to the interruption of normal retinal vascularization caused by premature birth, often exacerbated by oxygen therapy and other neonatal factors. The pathophysiology involves an initial phase of vessel growth arrest followed by hypoxia-induced pathological neovascularization. Clinically, ROP can range from mild, self-limited disease to severe stages with retinal detachment and permanent vision loss. The condition is classified by zones of retinal involvement and stages of severity, which guide prognosis and management. It is a leading cause of preventable childhood blindness in developed and developing countries.

Inciting Event

Locked content.

Latency Period

Locked content.

Diagnostic Delay

Locked content.

Clinical Presentation


Signs & Symptoms

Locked content.

History of Present Illness

Locked content.

Past Medical History

Locked content.

Family History

Locked content.

Physical Exam Findings

Locked content.

Diagnostic Workup


Diagnostic Criteria

Locked content.

Pathophysiology


Key Mechanisms

Locked content.

Organs

Locked content.

Tissues

Locked content.

Cells

Locked content.

Chemical Mediators

Locked content.

Treatments


Pharmacological Treatments

Locked content.

Non-pharmacological Treatments

Locked content.

Prevention


Pharmacological Prevention

Locked content.

Non-pharmacological Prevention

Locked content.

Outcome & Complications


Complications

Locked content.

Short-term Sequelae

Locked content.

Long-term Sequelae

Locked content.

Differential Diagnoses


Differentials

Locked content.

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site's content were generated or assisted by AI. All material has been reviewed by Erik Romano, MD, however, errors or omissions may still occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. “USMLE Step 1” and “USMLE Step 2 CK” are used only to identify the relevant examinations.